Treatment of Secondary Hyperparathyroidism by Intravenous Calcitriol
Publisher
Springer London
Reference21 articles.
1. Wilson L, Felsenfeld A, Drezner MK, Llach F: Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D. Kidney Int, 27: 565–573, 1985.
2. Llach F, Massry SG: On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab, 61: 601–606, 1985.
3. Brickman AS, Coburn JW, Norman AW: Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3 in uremic man. N Engl J Med, 287: 891–895, 1972.
4. Chan JCM, Oldham SB, Holick MF et al: Alpha hydroxyvitamin D3 in chronic renal failure: A potent analogue of the kidney hormone 1,25 dihydroxycholecalciferol. JAMA, 234: 47–52, 1975.
5. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM: Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin Invest, 78: 1296–1301, 1986.